Chicago Equity Partners’s Charles River Laboratories CRL Stock Holding History

Chicago Equity Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-43,005	Closed	-$3.41M	–	483
2015 Q1	$3.41M	Sell	43,005 -29,330	-41%	-$2.16M	0.09%	175
2014 Q4	$4.6M	Sell	72,335 -11,760	-14%	-$737K	0.12%	160
2014 Q3	$5.02M	Buy	84,095 +12,040	+17%	+$689K	0.13%	148
2014 Q2	$3.86M	Sell	72,055 -1,585	-2%	-$87K	0.1%	169
2014 Q1	$4.44M	Buy	73,640 +13,200	+22%	+$769K	0.12%	159
2013 Q4	$3.21M	Sell	60,440 -425	-0.7%	-$21.3K	0.1%	176
2013 Q3	$2.81M	Buy	60,865 +675	+1%	+$31K	0.09%	190
2013 Q2	$2.47M	Buy	+60,190	New	+$2.58M	0.08%	197

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chicago Equity Partners's CRL Position: Q2 2015 in Review

Chicago Equity Partners sold out of Charles River Laboratories (CRL) in Q2 2015, closing a stake of 43,005 shares — an estimated $3.41M sold.

Chicago Equity Partners first reported a position in CRL in Q2 2013 and held it in 8 quarters. The position peaked at $5.02M in Q3 2014. 261 funds tracked by Wall St. Rank hold CRL as of Q2 2015.

Chicago Equity Partners reported no remaining Charles River Laboratories position as of Q2 2015 after selling out during the quarter.
Chicago Equity Partners sold 43,005 Charles River Laboratories shares in Q2 2015, an estimated $3.41M.
Chicago Equity Partners first reported a position in Charles River Laboratories in Q2 2013 and held it in 8 quarters.
Chicago Equity Partners's Charles River Laboratories position peaked at $5.02M in Q3 2014.
261 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2015.

Based on Chicago Equity Partners's 13F filing for Q2 2015, filed 7 Aug 2015.